2nd EFMC2 Tandem Talks

EFMC² Tandem Talks, jointly organised by the EFMC and the EFMC Computational Chemistry Initiative (EFMC²), returns to give you real life insights into how medicinal and computational chemists can successfully drive projects together, featuring a balanced perspective from both sides.

Join us for the second edition of this already succesful online seminar and discussion format, to hear about case studies where collaboration between the disciplines was key and discuss what makes the essence of successful MedChem-CompChem interaction now and in the future.

PROGRAMME: 

• BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe
• Dr Léa BOUCHE, F. Hoffmann-La Roche (formerly Bayer), Switzerland 
• Dr Judith GÜNTHER, Bayer, Germany

• Round Table Discussion, moderated by
• Prof. Andreas BENDER, University of Cambridge, United Kingdom
• Dr Hayley BINCH, F. Hoffmann-La Roche, Switzerland 

More information & registration on https://www.efmctandemtalks.org/

The event is free and open to everyone thanks to the support of Evolvus.

Organising Committee
Dr Clara CHRIST, Bayer, Germany
Prof. Andreas BENDER, University of Cambridge, United Kingdom
Dr Hayley BINCH, F. Hoffmann-La Roche, Switzerland
Dr Richard LEWIS, Novartis, Switzerland
Dr Franz VON NUSSBAUM, Nuvisan, Germany